If you or someone you love was just diagnosed with type 2 diabetes, the doctor probably rattled off a to-do list: Watch your blood sugar, lose a few pounds, move more, and — if you’re over 40 — consider a cholesterol pill.
That last item usually gets shrugged off. Cholesterol feels like a problem for later. A recent study of 132,585 people suggests “later” may be the most expensive word in that sentence.
Researchers in Denmark found that people who started a statin within a year of their diabetes diagnosis had a 15% lower relative risk of dementia over the following decade than those who never took one. Wait one to five years to start, and the advantage shrank to 10%.
I’m 71. Like most people my age, I know the fear of dementia better than I know the fear of a heart attack. So I read this one closely. Here’s what it says, what it doesn’t, and what to ask your doctor.
What the study found
The research was presented at the European Society of Cardiology’s annual congress in Munich in August and published in The Lancet Regional Health — Europe.
Using Denmark’s national health registers, a team led by Dr. Tummas Ternhamar of Copenhagen University Hospital tracked 132,585 adults diagnosed with type 2 diabetes between 2006 and 2019. None had taken a statin before.
The researchers followed them for a median of 7.1 years, through the end of 2021.
During that time, 2.7% of them developed dementia.
Then the team sorted the group by when, if ever, they started a statin: within the first year of diagnosis, one to five years later, or never.
The early starters came out ahead. Their relative risk of dementia over 10 years was 15% lower than non-users. Late starters got roughly two-thirds of that benefit, at 10% lower.
Put in absolute terms, as ScienceAlert reported from the paper, about 3.9% of the never-statin group developed dementia within 10 years, compared with 3.5% of late starters and 3.3% of early starters.
Why it might work
Nobody’s claiming statins are a memory drug. The likelier explanation is plumbing.
Diabetes is hard on blood vessels, including the tiny ones feeding your brain. The National Institute of Diabetes and Digestive and Kidney Diseases puts it bluntly: “Having diabetes means you are more likely to develop heart disease.”
That’s why the same agency says people with diabetes over 40 “may need to take medicine, such as a statin.”
Statins lower LDL cholesterol, the kind that clogs arteries. Healthier arteries mean fewer small strokes and less of the vascular damage that contributes to many dementias. Start protecting the pipes sooner, the theory goes, and the brain downstream fares better.
Dr. Ternhamar’s own summary was careful: Early statin use following a type 2 diabetes diagnosis “could be associated with a lower risk of dementia.” Could be. Associated. Those words are doing real work, which brings us to the caveats.
What the study can’t tell you
This was an observational study, not a randomized trial. Nobody flipped a coin to decide who got a statin. People who start medication promptly may also be the people who show up for checkups, take their metformin and walk after dinner.
The researchers used statistical methods designed to mimic a randomized trial and strip out some of that bias, but they can’t remove all of it.
Professor Isabel Goncalves, who commented on the findings for the cardiology society, said it plainly: “This was an observational study, so it cannot prove that statins prevent dementia.”
The study was also Danish. Denmark’s population is less diverse than ours, and its health system is very different. The press releases note that results were similar between men and women but don’t give the group’s average age.
And a 15% relative reduction on a roughly 4% risk is a modest absolute change — meaningful across millions of people, but not a guarantee for any one of them.
A quick nudge — when it comes to money, the best day to get smart was 20 years ago. The second-best is today. Sign up for the free Money Talks Newsletter and start now. Takes 10 seconds, costs nothing, and could change your retirement.
Why this matters to so many of us
The Centers for Disease Control and Prevention estimates that 40.1 million Americans have diabetes, about 12% of the population, and 27.6% of adults who have it don’t know it. Among people 65 and older, 52.1% — 31.3 million — have prediabetes.
Meanwhile, the Alzheimer’s Association estimates 7.4 million Americans 65 and older are living with Alzheimer’s. That’s about 1 in 9.
Put those two groups side by side and you see why a cheap, generic pill that might nudge the second number down is worth a conversation.
And it is cheap. Generic statins have been around for decades, they’re on essentially every Medicare Part D formulary, and many cost less than a fancy coffee for a month’s supply. Nobody’s getting rich off the findings in this study.
What to ask your doctor
If you have type 2 diabetes — especially a recent diagnosis — and you’re not on a statin, here’s the conversation to have.
Ask whether you should be on one anyway. Federal guidance already suggests statins for many people with diabetes over 40, dementia or no dementia. If your doctor has been letting it slide because your cholesterol “isn’t that bad,” ask whether the diabetes changes the math.
Ask about timing. The study’s key finding wasn’t that statins help. It was that starting sooner appeared to help more. If you’ve been putting it off, this is a reason to stop.
Ask about side effects. Muscle aches are the most common complaint, and they’re real for some people, though not every ache is the pill’s fault. There are several statins at several doses. Switching is usually easier than quitting.
Don’t stop anything on your own. If you’re already taking one, this study is good news, not a reason to change course. If you’re not, it’s a reason to talk, not to self-prescribe.
The bottom line
I’ve spent 35-plus years telling people the best time to start saving was yesterday and the second-best time is today. It turns out the same rule may apply to protecting your brain after a diabetes diagnosis.
This study doesn’t prove statins prevent dementia. It does suggest that people who acted early fared better than people who waited. That’s the kind of odds I’d want on my side.
If you’d rather work on the problem without a prescription, here are 10 science-backed ways to cut your risk of Alzheimer’s that can work alongside a statin.
Add a Comment